Vice President Biden ties Providence to Cancer Moonshot
June 30, 2016
More than 150 people took part as Providence Cancer Institute participated in Vice President Biden’s Cancer Moonshot Summit. The goal is to make a decade worth of advances toward a cure in five years, from increasing access to treatment and improving care to freeing trapped data and unleashing new breakthroughs.
Following Vice President Biden’s address, there was a panel discussion about Providence Cancer Institute’s work in immunotherapy. The audience heard from members of the research and development team, including: Shari Scales, CFRE, director of development; Will Redmond, Ph.D., associate member, laboratory of cancer immunotherapy; Walter J. Urba, M.D., Ph.D., director of cancer research, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute; and Rom Leidner, M.D., aerodigestive oncology and clinical investigator.
Providence Cancer Institute/Earle A. Chiles Research Center was the only site in Oregon invited to participate in the vice president’s roundtable discussion because of its work as part of the Oncology Precision Network (OPN). Providence, Intermountain Healthcare and Stanford Cancer Institute developed OPN as a way to advance treatments for cancer through increasing access to clinical trials and data sharing. The network currently brings together genomics data and physicians across 11 states, 79 hospitals and 800 clinics, with plans to add at least five new health care systems in the next 12 months.
Additional coverage of Providence and the Cancer Moonshot: